Earnings Insights
AI-generated analysis of quarterly earnings, concall highlights, and financial performance across Indian listed companies.
How to use these insights
Each article is built from earnings call transcripts and structured rank signals. Start with the latest summary, then open the stock page for the full company view, the concall page for quarter-by-quarter commentary, and the rankings dashboard to compare peers.
Bajaj Housing Finance Q4 FY25 earnings call: Revenue & Margins | Arthneeti
Q4 FY25
Home Loans grew by 22%, Loan Against Property (LAP) by 28%, Lease Rental Discounting (LRD) by 24%, and Developer Finance by 49% in the recent quarter. Key…
6 Aug 2026
Bajaj Housing Finance Q3 FY25 earnings call: Revenue & Margins | Arthneeti
Q3 FY25
Developer finance will grow but remain a controlled portion (12%-15% of portfolio) due to risk considerations, supporting home loan growth indirectly (pages…
6 Aug 2026
Baazar Style Retail Q3 FY26 earnings call: Revenue & Margins | Arthneeti
Q3 FY26
Revenue grew 38% year-on-year to INR1,376 crores in 9-month FY '26, backed by strong growth in core and focus markets (Page 6). Key concall takeaways from…
6 Aug 2026
Baazar Style Retail Q3 FY25 earnings call: Revenue & Margins | Arthneeti
Q3 FY25
New stores typically mature over 3 years, achieving operating margins of 5% in year one, 8%-10% in year two, and 14%-16% in year three. Key concall takeaways…
6 Aug 2026
Interarch Building Solutions Q2 FY26 earnings call: Revenue & Margins | Arthneeti
Q2 FY26
Full operational capacity for FY '26 and FY '27 should enable revenues above INR 2,000 crores. Key concall takeaways from Interarch Building Solutions Ltd's Q2…
6 Aug 2026
Interarch Building Solutions Q1 FY26 earnings call: Revenue & Margins | Arthneeti
Q1 FY26
1,700 crores. Key concall takeaways from Interarch Building Solutions Ltd's Q1 FY26 earnings call — and how it ranks against sector peers.
6 Aug 2026
Interarch Building Solutions Q4 FY25 earnings call: Revenue & Margins | Arthneeti
Q4 FY25
As of April 30, 2025, Interarch's total order book stands at approximately INR 1,646 crores. Key concall takeaways from Interarch Building Solutions Ltd's Q4…
6 Aug 2026
Interarch Building Solutions Q3 FY25 earnings call: Revenue & Margins | Arthneeti
Q3 FY25
Post-FY26, growth could accelerate further to 20-25% annually due to increased capacity utilization and operating leverage. Key concall takeaways from…
6 Aug 2026
VVIP Infratech Q1 FY26 earnings call: Revenue & Margins | Arthneeti
Q1 FY26
They plan to focus on larger tenders in the ₹300-500 crore range to leverage their technical expertise. Key concall takeaways from VVIP Infratech Ltd's Q1 FY26…
6 Aug 2026
Sahaj Solar Q4 FY25 earnings call: Revenue & Margins | Arthneeti
Q4 FY25
Upcoming capacity expansions, including the first 750 additional capacity and new manufacturing lines (e.g., TOPCon panels with >21% efficiency), will enable…
6 Aug 2026
S A Tech Software India Q4 FY25 earnings call: Revenue & Margins | Arthneeti
Q4 FY25
100 crores to Rs. Key concall takeaways from S A Tech Software India Ltd's Q4 FY25 earnings call — and how it ranks against sector peers.
6 Aug 2026
Ceigall India Q3 FY26 earnings call: Revenue & Margins | Arthneeti
Q3 FY26
Ceigall plans to leverage a strong order book (~INR13,295 crores) with multi-year revenue visibility. Key concall takeaways from Ceigall India Ltd's Q3 FY26…
6 Aug 2026
Akums Drugs & Pharmaceuticals Q1 FY26 earnings call: Revenue & Margins | Arthneeti
Q1 FY26
300 crores linked to European markets. Key concall takeaways from Akums Drugs & Pharmaceuticals Ltd's Q1 FY26 earnings call — and how it ranks against sector…
6 Aug 2026
Akums Drugs & Pharmaceuticals Q4 FY25 earnings call: Revenue & Margins | Arthneeti
Q4 FY25
API Business:** Planning ~10% volume growth but revenues and profits dependent on Cephalosporin prices. Key concall takeaways from Akums Drugs &…
6 Aug 2026
Akums Drugs & Pharmaceuticals Q3 FY25 earnings call: Revenue & Margins | Arthneeti
Q3 FY25
12%-13% revenue growth. Key concall takeaways from Akums Drugs & Pharmaceuticals Ltd's Q3 FY25 earnings call — and how it ranks against sector peers.
6 Aug 2026
Ola Electric Mobility Q3 FY26 earnings call: Revenue & Margins | Arthneeti
Q3 FY26
. Key concall takeaways from Ola Electric Mobility Ltd's Q3 FY26 earnings call — and how it ranks against sector peers.
6 Aug 2026
Bansal Wire Industries Q1 FY26 earnings call: Revenue & Margins | Arthneeti
Q1 FY26
Revenue growth complemented by product mix changes and backward integration, with capex of about INR 700-750 crores planned over FY '26 and FY '27 primarily…
6 Aug 2026
Bansal Wire Industries Q4 FY25 earnings call: Revenue & Margins | Arthneeti
Q4 FY25
Historically, the company has achieved 20%-25% volume growth, outpacing the industry growth of 6%-7%. Key concall takeaways from Bansal Wire Industries Ltd's…
6 Aug 2026
Emcure Pharmaceuticals Q1 FY26 earnings call: Revenue & Margins | Arthneeti
Q1 FY26
International markets showed strong momentum, growing 22% YoY, with emerging markets growing 42%. Key concall takeaways from Emcure Pharmaceuticals Ltd's Q1…
6 Aug 2026
Emcure Pharmaceuticals Q3 FY25 earnings call: Revenue & Margins | Arthneeti
Q3 FY25
R&D spend is maintained at 4%-5% to support innovation and biologics. Key concall takeaways from Emcure Pharmaceuticals's Q3 FY25 earnings call — and how it…
6 Aug 2026